Early stage diagnosis offers the most favorable prognosis for cancer treatment. Although conventional screening methods ...

Raymond Osarogiagbon, MD, highlights the potential benefits of increasing screening rates for patients diagnosed with lung cancer and the broader US health care system.

Although lung cancer screening ... A Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions Mar. 17, 2025 — In the continuing evolution of personalized medicine, a new study has ...

Blocking proteins that cause cancer cells to mutate and resist treatment could significantly improve outcomes for some ...

Susan Riffle had a lesion on her lung that AI determined was likely cancer. The disease was caught at stage 1, and she ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Expanding accessibility to early detection would improve treatment outcomes, reduce mortality, and minimized the emotional ...

A new study presented at ESTRO 2025 introduces the RAPID-RT study, which uses an innovative rapid-learning approach to ...

Dr. Neha Mehta-Shah shares how patients can better understand their subtype of rare lymphoma, as well as expands on the ...

The RAPID-RT study, led by researchers at The Christie NHS Foundation Trust in Manchester, UK, evaluates the impact of modifying radiotherapy treatments in real-world lung cancer patients.

May is National Cancer Research Month. Join us in honoring the work being done to develop new cancer treatment options for ...

The world of oncology is evolving rapidly, with breakthrough technologies transforming the way cancer is treated and managed.